What are the AAN guidelines on mild cognitive impairment (MCI)?

Updated: Apr 22, 2019
  • Author: Sonal Mehta, MD; Chief Editor: Jasvinder Chawla, MD, MBA  more...
  • Print


The 2017 update of the American Academy of Neurology guideline on mild cognitive impairment (MCI), which is endorsed by the Alzheimer's Association, recommends that patients with MCI exercise regularly as part of an overall approach to managing their symptoms. [37] The guideline also advises clinicians to do the following:

  • assess for MCI using validated tools in appropriate scenarios (level B);

  • evaluate patients with MCI for modifiable risk factors, assess for functional impairment, and assess for and treat behavioral/neuropsychiatric symptoms (level B);

  • monitor cognitive status of patients with MCI over time (level B);

  • stop cognitively impairing medications where possible, and treat behavioral symptoms (level B);

  • consider not offering cholinesterase inhibitors (level B), and if offering, first discuss lack of evidence (level A);

  • recommend regular exercise (level B);

  • consider recommending cognitive training (level C);

  • discuss diagnosis, prognosis, long-term planning, and the lack of effective drug options (level B); and

  • consider discussing biomarker research with patients with MCI and families (level C).

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!